Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EPA Gives Stakeholders Additional 15 Days For EtO Comments

Executive Summary

The deadline for comments on the Environmental Protection Agency proposal, which trade groups say could lead to device shortages if implemented, has been moved from 12 June to 27 June. 

You may also be interested in...



Harmonizing EPA And Industry Needs: EtO Emissions

The EPA and medtech industry want the same things: Cleaner air and a steady supply of medical devices. So how do they reconcile their differences?

To Reuse, Or Not To Reuse: The Pros And Cons Of Reprocessed Endoscopic Devices

During MD&M East in New York, Robert Austring, vice president of sales and marketing at Precision Optics, described the opportunities and challenges of marketing either reusable or single-use endoscopic devices.

‘We Need More Time‘: Medtech Groups Testify Before EPA On ETO Emissions Regulation

Medtech groups call for extended commentary and compliance periods for two new EtO regulations from the EPA. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel